:

Homeland Security

Osiris Nabs $225M DoD Contract for Acute Radiation Syndrome

DDN

Wednesday, January 9th, 2008

SHARE:

Osiris Therapeutics [OSIR] won a potential $224.7 million contract from the Defense Department for the development and possible purchase of Prochymal, an adult stem cell therapy, for the repair of gastrointestinal injury resulting from radiation exposure. Initially Osiris will receive $4.2 million this year to continue development of Prochymal for acute radiation syndrome (ARS). Once the Food and Drug Administration (FDA) approves the drug for ARS, the contract provides for the purchase of up to 20,000 doses, at $10,000 per…

Navy Leaders Downplay Looking At Foreign Navy Shipbuilding Amid Lawmaker Objections

The Navy’s top leaders this week seemed to downplay and back down on the service potentially using foreign shipyards to build U.S. Navy ships or buying foreign designed warships overseas […]

Army

Senate Defense Appropriators See ‘Risk’ With Army’s Reconciliation Plan To Fund Munitions Increase

The Senate’s top defense appropriators cited concern this week with the Army’s request to fund the majority of its large increase to munitions procurement in fiscal year 2027 through the […]

Army

Army Relooking At Its ‘Whole Aviation Transformation’ Plan, Acting Chief Tells Lawmakers

The Army is relooking at its “whole aviation transformation initiative,” the service’s acting chief of staff told lawmakers on Tuesday, to include its approach for future procurement of “enduring” platforms. […]

Army

Lawmakers Request DoD Briefing On Army’s Planned Cuts To Aviation Procurement

A bipartisan group of House lawmakers has sent a letter asking the Pentagon for a briefing on the potential industrial base impacts as a result of the Army’s planned cuts […]